Specialty Pharmaceutical Management

Online Registration is open!

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200

Need Technical Assistance With this Website?
Send an email to IIR's Web Department

May 21 - 23, 2007 | Boston Marriott Copley Place, Boston, MA

8:30	Morning Coffee
8:45	Chair's Welcoming Remarks Terrance Killilea, Pharm.D, Director, Pharmacy Services THE REGENCE GROUP
9:00	Case Study: Learn from Gillette's Example of Achieving Cost Savings Through Its In Vitro Fertilization Program J. Brooks Watt, MD, Medical Director GILLETTE GBU, A DIVISION OF PROCTER AND GAMBLE
9:45	The Value of Biologics and Health Outcomes Data to Verify Health Care Costs, Productivity & Quality of Life Denise R. Globe, Ph.D., Director, Global Health Economics AMGEN Vaishali Patel, PharmD, Senior Manager, Global Health Economics AMGEN
10:15	What Specialty Pharmacies Must Do to Improve the Distribution Channel Rebecca Shanahan, President, OTN SPECIALTY SERVICES
11:00	Networking Break
11:30	Distribution Models - Understanding the Limitations Your Specialty Pharmacy May Face Stephen L. Collins, President SL COLLINS CONSULTING INC.
12:15	Luncheon
1:30	Evidence-Based Evaluation of Biotherapeutics: The Value of Separation from Distribution and Pricing Terrance Killilea, Pharm.D, Director, Pharmacy Services THE REGENCE GROUP
2:00	Transparency in Specialty Pharmacy: Caveat Emptor Robert Taketomo, Pharm.D., M.B.A., President/CEO VENTEGRA, LLC
2:30	Panel Discussion on What a Good Specialty Program Should Look Like Moderated by a Health Plan with Specialty Pharmacy Companies and PBMs
3:15	Conference Concludes